Page 9 - Gene Therapy Program News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

/PRNewswire/ -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, announced that the company will...

Regulatory setbacks for a new migraine treatment have led Zosano Pharma to restructure, laying off about 31% of its staff. Zosano is one of several biotechs that announced cost-saving measures this week.

(RTTNews) - Passage Bio, Inc. (PASG) said on Tuesday that it will cut jobs by around 13 percent to reduce operating expenses and prioritize its re...

Troutman Pepper Advises Center for Breakthrough Medicines in Partnership with University of Pennsylvania for Gene Therapy Manufacturing.

This CBM partnership with GTP is focused on moving therapeutics safely and rapidly from concept to clinic by connecting certain of Penn’s established gene therapy platforms with CBM’s manufacturing and analytical capacity.

Passage Bio is doubling down on its lead clinical program, a gene therapy designed to treat GM1 gangliosidosis, after interim clinical data from a Phase I/II trial showed developmental improvement in two young boys with the late infantile form of the inherited lysosomal storage disorder, after receiving a low dose of PBGM01.

Both children with late infantile GM1 gangliosidosis in Cohort 1 of the Imagine-1 clinical trial showed developmental improvement in assessments by study...

/PRNewswire/ -- The Center for Breakthrough Medicines (CBM) and the University of Pennsylvanias Gene Therapy Program (GTP) have signed a landmark...

/PRNewswire/ -- The Center for Breakthrough Medicines (CBM) and the University of Pennsylvanias Gene Therapy Program (GTP) have signed a landmark...